ARTICLE | Distillery Therapeutics
Cancer; infectious disease
November 6, 2017 7:55 PM UTC
Mouse studies suggest inhibiting SIGIRR could help treat liver cancer, sarcoma, colon cancer and CMV infection. In a mouse model of hepatocellular carcinoma (HCC), systemic SIGIRR knockout decreased d...
BCIQ Company Profiles
BCIQ Target Profiles
Single immunoglobulin and toll-interleukin 1 receptor domain (SIGIRR) (TIR8)